| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 93421 |
DOTA (Tyr3) octreotate,204318-14-9,依多曲肽 |
151 |
zyl |
2024-11-21 |
| 93422 |
DOTA-生物素-肌氨酸,CAS号:180978-54-5 |
160 |
wyh |
2024-11-21 |
| 93423 |
环氧功能化单体插入率的降冰片烯共聚物, rP(BN/MGENB)-x |
150 |
kx |
2024-11-21 |
| 93424 |
吡啶鎓官能化的聚降冰片烯4-n(n=1,2,3) |
195 |
kx |
2024-11-21 |
| 93425 |
环状肽909024-55-1,DOTA-cyclo(RGDfK) acetate |
152 |
zyl |
2024-11-21 |
| 93426 |
p-NH2-Bn-DOTA ,CAS号:123317-52-2 |
248 |
wyh |
2024-11-21 |
| 93427 |
碘代丙炔基丁基氨基甲酸酯;3-iodo-2-propynyl butylcarbamate;IPBC |
239 |
WYQ |
2024-11-21 |
| 93428 |
大环化合物DOTA-(COOt-Bu)3-NHFmoc-Lys |
161 |
zyl |
2024-11-21 |
| 93429 |
N-苯基-5-降冰片烯-2,3-二羰基酰亚胺(C15H13NO2)晶体 |
166 |
kx |
2024-11-21 |
| 93430 |
甲基丙烯酸丙炔基酯(PgMA) |
397 |
WYQ |
2024-11-21 |
| 93431 |
-丙炔基咔唑(PC)是一种有机化合物 |
283 |
WYQ |
2024-11-21 |
| 93432 |
1,4,7,10-四氮杂环十二烷-1,4,7-三(乙酸)-10(3-丁炔基乙酰胺) |
157 |
wyh |
2024-11-21 |
| 93433 |
7-(3'-哌啶基丙炔基)喜树碱(CPT21) |
149 |
WYQ |
2024-11-21 |
| 93434 |
双环肽螯合物DOTA-E「c(RGDyK)2」,DOTA标记序列多肽 |
236 |
zyl |
2024-11-21 |
| 93435 |
双功能螯合物DOTA-GGGA;149206-86-0 |
159 |
wyh |
2024-11-21 |
| 93436 |
二茂铁吡啶鎓和聚乙二醇的降冰片烯共聚物 , P-NB-Py-Fc-PEG |
191 |
kx |
2024-11-21 |
| 93437 |
碘丙炔基正丁胺甲酸酯(IPBC) |
239 |
WYQ |
2024-11-21 |
| 93438 |
炔丙基-甲基丙烯酸酯,也被称为甲基丙烯酸丙炔基酯 |
209 |
WYQ |
2024-11-21 |
| 93439 |
丙炔基功能化的L-谷氨酸酯-N-羧酸内酸酐(PPLG-NCA) |
173 |
WYQ |
2024-11-21 |
| 93440 |
gadolinium(3+),2-[4,7,10-tris(carboxylatomethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetate |
147 |
wyh |
2024-11-21 |
| 93441 |
丙炔基甘氨酸(PAG) |
460 |
WYQ |
2024-11-21 |
| 93442 |
5-碘甲基降冰片烯 , IMNB |
214 |
kx |
2024-11-21 |
| 93443 |
整合素DOTA-E-[cyclo(RGDfK(Acp))]2 |
155 |
zyl |
2024-11-21 |
| 93444 |
DOTA-E[CYCLO(RGDFK)]2探针多肽 |
181 |
wyh |
2024-11-21 |
| 93445 |
DOTA-JR-11,1039726-31-2,放射显影多肽 |
166 |
zyl |
2024-11-21 |
| 93446 |
5-降冰片烯-2-亚甲基环氧丙基醚 , NB-MGE |
159 |
kx |
2024-11-21 |
| 93447 |
DO3A-Thiol ;CAS:865470-67-3 DOTA-SH |
143 |
wyh |
2024-11-21 |
| 93448 |
七肽DOTA-VLASSAR,CAS号:1262403-90-6 |
159 |
zyl |
2024-11-21 |
| 93449 |
Gd-DOTA-HCBP的组成结构 |
173 |
wyh |
2024-11-21 |
| 93450 |
双阳离子中心咪唑功能化降冰片烯离子液体单体 , NB-O-Im+Br--Im+Br- |
199 |
kx |
2024-11-21 |
| 93451 |
479081-06-6 ;DOTA-(COOt-Bu)3-NHFmoc-Lys |
161 |
wyh |
2024-11-21 |
| 93452 |
DOTA-TATE,CAS:177943-89-4, DOTA-3-酪氨酰基-奥曲肽 |
150 |
zyl |
2024-11-21 |
| 93453 |
DOTA-octreotide的组成与结构 |
173 |
wyh |
2024-11-21 |
| 93454 |
endo-N-3,5-双三氟甲基联苯基降冰片烯酰亚胺, endo-PTNDI |
163 |
kx |
2024-11-21 |
| 93455 |
DOTA-Octreotide 大环配体奥曲肽 |
198 |
zyl |
2024-11-21 |
| 93456 |
端丙炔基聚乙二醇(PTPEG) |
208 |
WYQ |
2024-11-21 |
| 93457 |
CAS:127985-74-4,DOTA-p-NCS-Bn多肽标记的双功能螯合剂 |
147 |
wyh |
2024-11-21 |
| 93458 |
降冰片烯-异戊二烯共聚物 ,NBE-IP |
226 |
kx |
2024-11-21 |
| 93459 |
cyclo(RGDFK(DOTA))的特性与功能 |
148 |
wyh |
2024-11-21 |
| 93460 |
DOTA-cyclo(RGDfK) |
134 |
zyl |
2024-11-21 |
| 93461 |
Lu-DOTA-TATE;镥-大环配体-TATE多肽 |
507 |
wyh |
2024-11-21 |
| 93462 |
顺-5-降冰片烯-内型-2,3-二羧酸二乙酯 , endo-NDDE |
185 |
kx |
2024-11-21 |
| 93463 |
DOTA-NCS,DOTA-p-NCS-Bn,cas:127985-74-4 |
144 |
zyl |
2024-11-21 |
| 93464 |
DOTA-PEG-CPP;大环配体DOTA-聚乙二醇-酪蛋白磷酸肽 |
167 |
wyh |
2024-11-21 |
| 93465 |
Gd-DOTA-COOH 钆-四氮杂环配体-羧基 |
175 |
zyl |
2024-11-21 |